Clinical trials
Alzheimer Disease trials in Denmark
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
56 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 2 |
| 2004 | 1 |
| 2006 | 2 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 1 |
| 2012 | 3 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 3 |
| 2016 | 2 |
| 2017 | 4 |
| 2018 | 2 |
| 2019 | 5 |
| 2020 | 6 |
| 2021 | 2 |
| 2022 | 5 |
| 2023 | 2 |
| 2024 | 3 |
| 2025 | 4 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 27 |
| Terminated | 14 |
| Active, not recruiting | 5 |
| Unknown status | 4 |
| Recruiting | 4 |
| Not yet recruiting | 1 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hoffmann-La Roche | 11 |
| Zealand University Hospital | 5 |
| Rigshospitalet, Denmark | 4 |
| Danish Dementia Research Centre | 3 |
| University of Aarhus | 3 |
| AbbVie | 2 |
| Biogen | 2 |
| Bristol-Myers Squibb | 2 |
| Eidos Therapeutics, a BridgeBio company | 2 |
| H. Lundbeck A/S | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alzheimer Disease | 56 |
| Cognitive Dysfunction | 9 |
| Dementia | 9 |
| Lewy Body Disease | 5 |
| Dementia, Vascular | 3 |
| Neurodegenerative Diseases | 3 |
| Amyloid Neuropathies, Familial | 2 |
| Amyloidosis | 2 |
| Brain Diseases | 2 |
| Cardiomyopathies | 2 |
Trials
Showing 51 to 56 of 56. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.